0907 (0907) Fair Value & Analysis

Healthcare · Market cap HK$53.2M

0 0907 0907 · HK

PriceHK$0.0610

Fair ValueHK$0.0909

Upside+49.0%

Quality35/100

Evidence: Low Range HK$0.0848 – HK$0.0970

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.0390 – HK$0.1040 · fair‑value band HK$0.0848 – HK$0.0970 · the HK$0.0610 price screens below the HK$0.0909 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0907 (0907) currently trades at HK$0.0610, while our model-based Fair Value estimate is HK$0.0909 — implying the stock looks roughly 49.0% undervalued today. We read business quality at 35/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 0907 generated revenue of HK$62.0M at a net margin of 4.3%. It earns a return on equity of 52.6%. Net debt stands at HK$36.0M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$62.0M

Revenue growth (YoY) +671%

Net margin 4.3%

Return on equity 52.6%

Free cash flow −HK$26.2M FY2025

Operating margin 16.6%

More key figures

Net debt HK$36.0M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0907 reported revenue of HK$14.5M in FY2025 versus HK$53.9M in FY2021, a compound −28.0%/yr. Reported net income was −HK$20.2M in FY2025.

Revenue −28.0%/yr

FY21 HK$53.9M

FY22 HK$15.3M

FY23 HK$21.7M

FY24 HK$24.0M

FY25 HK$14.5M

Net income

FY21 −HK$15.3M

FY22 −HK$177M

FY23 −HK$84.8M

FY24 −HK$59.4M

FY25 −HK$20.2M

Is 0907 fairly valued? → Check now

Similar stocks

6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Intuitive Surgical, Inc ISRG	$422.06	$165.35	-61%
EssilorLuxottica Société anonyme ESLOF	$205.86	$114.90	-44%
HOYA Corporation HOCPY	$178.46	$103.27	-42%
Medline Inc MDLN	$36.54	$30.66	-16%
Becton, Dickinson and Company BDX	$147.79	$124.26	-16%
Alcon Inc ALC	$65.18	$44.21	-32%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0907 (0907) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0909 versus a price of HK$0.0610 — about +49% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0907?

Our model-based fair value for 0907 is HK$0.0909 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0610.

What is the quality score of 0907?

0907 has a Quality Score of 35/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0907 (0907)?

0907 reported trailing-twelve-month revenue of about HK$62.0M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0907?

The net profit margin of 0907 is about 4.3%, meaning it keeps roughly 4.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.